Skip to main content
SpringerLink
Log in

Polymorphism in the Hsa-miR-4274 seed region influences the expression of PEX5 and enhances radiotherapy resistance in colorectal cancer

  • Research Article
  • Published:
Frontiers of Medicine Aims and scope Submit manuscript

Abstract

Identifying biomarkers for predicting radiotherapy efficacy is crucial for optimizing personalized treatments. We previously reported that rs1553867776 in the miR-4274 seed region can predict survival in patients with rectal cancer receiving postoperative chemoradiation therapy. Hence, to investigate the molecular mechanism of the genetic variation and its impact on the radiosensitivity of colorectal cancer (CRC), in this study, bioinformatics analysis is combined with functional experiments to confirm peroxisomal biogenesis factor 5 (PEX5) as a direct target of miR-4274. The miR-4274 rs1553867776 variant influences the binding of miR-4274 and PEX5 mRNA, which subsequently regulates PEX5 protein expression. The interaction between PEX5 and Ku70 was verified by co-immunoprecipitation and immunofluorescence. A xenograft tumor model was established to validate the effects of miR-4274 and PEX5 on CRC progression and radiosensitivity in vivo. The overexpression of PEX5 enhances radiosensitivity by preventing Ku70 from entering the nucleus and reducing the repair of ionizing radiation (IR)-induced DNA damage by the Ku70/Ku80 complex in the nucleus. In addition, the enhanced expression of PEX5 is associated with increased IR-induced ferroptosis. Thus, targeting this mechanism might effectively increase the radiosensitivity of CRC. These findings offer novel insights into the mechanism of cancer radioresistance and have important implications for clinical radiotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023; 73(1): 17–48

    Article  PubMed  Google Scholar 

  2. Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet 2019; 394(10207): 1467–1480

    Article  PubMed  Google Scholar 

  3. Pucci S, Polidoro C, Joubert A, Mastrangeli F, Tolu B, Benassi M, Fiaschetti V, Greco L, Miceli R, Floris R, Novelli G, Orlandi A, Santoni R. Ku70, Ku80, and sClusterin: acluster of predicting factors for response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2017; 97(2): 381–388

    Article  CAS  PubMed  Google Scholar 

  4. Liu W, Miao C, Zhang S, Liu Y, Niu X, Xi Y, Guo W, Chu J, Lin A, Liu H, Yang X, Chen X, Zhong C, Ma Y, Wang Y, Zhu S, Liu S, Tan W, Lin D, Wu C. VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance. Signal Transduct Target Ther 2021; 6(1): 322

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bartel DP. Metazoan MicroRNAs. Cell 2018; 173(1): 20–51

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Salzman DW, Weidhaas JB. SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer. Pharmacol Ther 2013; 137(1): 55–63

    Article  CAS  PubMed  Google Scholar 

  7. Shen C, Yan T, Wang Z, Su HC, Zhu X, Tian X, Fang JY, Chen H, Hong J. Variant of SNP rs1317082 at CCSlnc362 (RP11-362K14.5) creates a binding site for miR-4658 and diminishes the susceptibility to CRC. Cell Death Dis 2018; 9(12): 1177

    Article  PubMed  PubMed Central  Google Scholar 

  8. Wang W, Yang C, Nie H, Qiu X, Zhang L, Xiao Y, Zhou W, Zeng Q, Zhang X, Wu Y, Liu J, Ying M. LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA-135a binding site affects bladder cancer risk. Int J Cancer 2019; 144(6): 1345–1355

    Article  PubMed  Google Scholar 

  9. Chen H, Yin L, Yang J, Ren N, Chen J, Lu Q, Huang Y, Feng Y, Wang W, Wang S, Liu Y, Song Y, Li Y, Jin J, Tan W, Lin D. Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy. Cancer Biol Med 2023; 20(4): 297–316

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Huang Y, Feng Y, Ren H, Zhang M, Li H, Qiao Y, Feng T, Yang J, Wang W, Wang S, Liu Y, Song Y, Li Y, Jin J, Tan W, Lin D. Associations of genetic variations in microRNA seed regions with acute adverse events and survival in patients with rectal cancer receiving postoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys 2018; 100(4): 1026–1033

    Article  CAS  PubMed  Google Scholar 

  11. Landeros N, Corvalan AH, Musleh M, Quinones LA, Varela NM, Gonzalez-Hormazabal P. Novel risk associations between microRNA polymorphisms and gastric cancer in a Chilean population. Int J Mol Sci 2021; 23(1): 467

    Article  PubMed  PubMed Central  Google Scholar 

  12. Shkurnikov M, Nikulin S, Nersisyan S, Poloznikov A, Zaidi S, Baranova A, Schumacher U, Wicklein D, Tonevitsky A. LAMA4-regulating miR-4274 and its host gene SORCS2 play a role in IGFBP6-dependent effects on phenotype of basal-like breast cancer. Front Mol Biosci 2019; 6: 122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Liu S, Zhang HL, Li J, Ye ZP, Du T, Li LC, Guo YQ, Yang D, Li ZL, Cao JH, Hu BX, Chen YH, Feng GK, Li ZM, Deng R, Huang JJ, Zhu XF. Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis. Redox Biol 2023; 62: 102677

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lei G, Mao C, Yan Y, Zhuang L, Gan B. Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell 2021; 12(11): 836–857

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Wang X, Zhou Y, Min J, Wang F. Zooming in and out of ferroptosis in human disease. Front Med 2023; 17(2): 173–206

    Article  PubMed  Google Scholar 

  16. Zou Y, Henry WS, Ricq EL, Graham ET, Phadnis VV, Maretich P, Paradkar S, Boehnke N, Deik AA, Reinhardt F, Eaton JK, Ferguson B, Wang W, Fairman J, Keys HR, Dancik V, Clish CB, Clemons PA, Hammond PT, Boyer LA, Weinberg RA, Schreiber SL. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature 2020; 585(7826): 603–608

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ravindran R, Bacellar IOL, Castellanos-Girouard X, Wahba HM, Zhang Z, Omichinski JG, Kisley L, Michnick SW. Peroxisome biogenesis initiated by protein phase separation. Nature 2023; 617(7961): 608–615

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Chen X, Kang R, Kroemer G, Tang D. Organelle-specific regulation of ferroptosis. Cell Death Differ 2021; 28(10): 2843–2856

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Fujiki Y, Okumoto K, Honsho M, Abe Y. Molecular insights into peroxisome homeostasis and peroxisome biogenesis disorders. Biochim Biophys Acta Mol Cell Res 2022; 1869(11): 119330

    Article  CAS  PubMed  Google Scholar 

  20. Yan H, Talty R, Aladelokun O, Bosenberg M, Johnson CH. Ferroptosis in colorectal cancer: a future target? Br J Cancer 2023; 128(8): 1439–1451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: An online resource for prediction of microRNA binding sites. PLoS One 2018; 13(10): e0206239

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bandyopadhyay S, Mitra R. TargetMiner: microRNA target prediction with systematic identification of tissue-specific negative examples. Bioinformatics 2009; 25(20): 2625–2631

    Article  CAS  PubMed  Google Scholar 

  23. Bhattacharya A, Ziebarth JD, Cui Y. PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways. Nucleic Acids Res 2014; 42(Database issue): D86–D91

    Article  CAS  PubMed  Google Scholar 

  24. Paraskevopoulou MD, Georgakilas G, Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, Filippidis C, Dalamagas T, Hatzigeorgiou AG. DIANA- microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res 2013; 41(W1): W169–W173

    Article  PubMed  PubMed Central  Google Scholar 

  25. Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res 2020; 48(D1): D127–D131

    Article  CAS  PubMed  Google Scholar 

  26. Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. eLife 2015; 4: e05005

    Article  PubMed  PubMed Central  Google Scholar 

  27. Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne U, Creighton CJ, Varambally S. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia 2022; 25: 18–27

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 2020; 48(W1): W509–W514

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 2019; 10(1): 1523

    Article  PubMed  PubMed Central  Google Scholar 

  30. Huang S, Fantini D, Merrill BJ, Bagchi S, Guzman G, Raychaudhuri P. DDB2 is a novel regulator of Wnt signaling in colon cancer. Cancer Res 2017; 77(23): 6562–6575

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Burdak-Rothkamm S, Rothkamm K, McClelland K, Al Rashid ST, Prise KM. BRCA1, FANCD2 and Chk1 are potential molecular targets for the modulation of a radiation-induced DNA damage response in bystander cells. Cancer Lett 2015; 356(2 2 Pt B): 454–461

    Article  CAS  PubMed  Google Scholar 

  32. Han C, Liu Z, Zhang Y, Shen A, Dong C, Zhang A, Moore C, Ren Z, Lu C, Cao X, Zhang CL, Qiao J, Fu YX. Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling. Nat Immunol 2020; 21(5): 546–554

    Article  CAS  PubMed  Google Scholar 

  33. Sándor N, Schilling-Tóth B, Kis E, Fodor L, Mucsányi F, Sáfrány G, Hegyesi H. TP53inp1 gene is implicated in early radiation response in human fibroblast cells. Int J Mol Sci 2015; 16(10): 25450–25465

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bracker TU, Sommer A, Fichtner I, Faus H, Haendler B, Hess-Stumpp H. Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models. Int J Oncol 2009; 35(4): 909–920

    CAS  PubMed  Google Scholar 

  35. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487(7407): 330–337

    Article  Google Scholar 

  36. Huang D, Du C, Ji D, Xi J, Gu J. Overexpression of LAMC2 predicts poor prognosis in colorectal cancer patients and promotes cancer cell proliferation, migration, and invasion. Tumour Biol 2017; 39(6): 1010428317705849

    Article  PubMed  Google Scholar 

  37. Vasilogianni AM, Al-Majdoub ZM, Achour B, Peters SA, Rostami-Hodjegan A, Barber J. Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis. Front Oncol 2023; 13: 1010563

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Liu Y, Deguchi Y, Tian R, Wei D, Wu L, Chen W, Xu W, Xu M, Liu F, Gao S, Jaoude JC, Chrieki SP, Moussalli MJ, Gagea M, Morris J, Broaddus RR, Zuo X, Shureiqi I. Pleiotropic effects of PPARD accelerate colorectal tumorigenesis, progression, and invasion. Cancer Res 2019; 79(5): 954–969

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Köse B, Laar RV, Beekhuizen HV, Kemenade FV, Baykal AT, Luider T, Güzel C. Quantitative proteomic analysis of MCM3 in ThinPrep samples of patients with cervical preinvasive cancer. Int J Mol Sci 2023; 24(13): 10473

    Article  PubMed  PubMed Central  Google Scholar 

  40. Lou J, Wei L, Wang H. SCNN1A overexpression correlates with poor prognosis and immune infiltrates in ovarian cancer. Int J Gen Med 2022; 15: 1743–1763

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Cheng WL, Feng PH, Lee KY, Chen KY, Sun WL, Van Hiep N, Luo CS, Wu SM. The role of EREG/EGFR pathway in tumor progression. Int J Mol Sci 2021; 22(23): 12828

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Sui H, Hao M, Chang W, Imamichi T. The role of Ku70 as a cytosolic DNA sensor in innate immunity and beyond. Front Cell Infect Microbiol 2021; 11: 761983

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Yang MD, Tsai CW, Chang WS, Tsou YA, Wu CN, Bau DT. Predictive role of XRCC5/XRCC6 genotypes in digestive system cancers. World J Gastrointest Oncol 2011; 3(12): 175–181

    Article  PubMed  PubMed Central  Google Scholar 

  44. Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, Sell A, Wei S, Grove S, Johnson JK, Kennedy PD, Gijón M, Shah YM, Zou W. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 2022; 40(4): 365–378.e6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Quan J, Bode AM, Luo X. ACSL family: The regulatory mechanisms and therapeutic implications in cancer. Eur J Pharmacol 2021; 909: 174397

    Article  CAS  PubMed  Google Scholar 

  46. Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H, Gan B. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res 2020; 30(2): 146–162

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, Liao P, Zhou J, Zhang Q, Dow A, Saripalli AL, Kryczek I, Wei S, Szeliga W, Vatan L, Stone EM, Georgiou G, Cieslik M, Wahl DR, Morgan MA, Chinnaiyan AM, Lawrence TS, Zou W. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov 2019; 9(12): 1673–1685

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Cai M, Sun X, Wang W, Lian Z, Wu P, Han S, Chen H, Zhang P. Disruption of peroxisome function leads to metabolic stress, mTOR inhibition, and lethality in liver cancer cells. Cancer Lett 2018; 421: 82–93

    Article  CAS  PubMed  Google Scholar 

  49. Zhu H, Lin Y, Lu D, Wang S, Liu Y, Dong L, Meng Q, Gao J, Wang Y, Song N, Suo Y, Ding L, Wang P, Zhang B, Gao D, Fan J, Gao Q, Zhou H. Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma. Natl Sci Rev 2023; 10(8): nwad167

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work is supported by grants from the National Natural Science Foundation (Grant No. 81972859 to W.T.), CAMS Innovation Fund for Medical Sciences (CIFMS) (Grant No. 2021-I2M-1-013 to D.L. and W.T.), and State Key Laboratory of Molecular Oncology Grants (Grant No. SKLMO-2021-03 to W.T. and SKLMO-KF-2023-03 to D.L.)

Author information

Authors and Affiliations

  1. State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, Beijing Key Laboratory for Carcinogenesis and Cancer Prevention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China

    Qixuan Lu, Ningxin Ren, Hongxia Chen, Shaosen Zhang, Ruoqing Yan, Mengjie Li, Linlin Zheng, Wen Tan & Dongxin Lin

  2. Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, 510060, China

    Dongxin Lin

Authors
  1. Qixuan Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ningxin Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hongxia Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shaosen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ruoqing Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mengjie Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Linlin Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wen Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dongxin Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Wen Tan or Dongxin Lin.

Ethics declarations

Conflicts of interest Qixuan Lu, Ningxin Ren, Hongxia Chen, Shaosen Zhang, Ruoqing Yan, Mengjie Li, Linlin Zheng, Wen Tan, and Dongxin Lin declare that they have no conflict of interest.

The study was approved by the appropriate institutional and/or national research ethics committee and the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all patients for being included in the study. All institutional and national guidelines for the care and use of laboratory animals were followed.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lu, Q., Ren, N., Chen, H. et al. Polymorphism in the Hsa-miR-4274 seed region influences the expression of PEX5 and enhances radiotherapy resistance in colorectal cancer. Front. Med. (2024). https://doi.org/10.1007/s11684-024-1082-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11684-024-1082-6

Keywords

Search

Navigation